🔁 1/3 🧵 Rx Update | 🫀🧒 Pediatric Endocarditis 💬 ⚕️ By recent UConn Pharmacy grad Hira I. Can some stable pediatric endocarditis patients transition from IV to PO abxs? Early data suggest it may be promising, but more studies needed. Read more: pharmacy.uconn.edu/pediatric-id... #PedsIDsky #Rxsky

🔁 1/3 🧵 Pharmacy Update | 🧸👂 Pediatric AOM Stewardship 💬 ⚕️ By recent UConn Pharmacy Grad Tim R. 👂 Watchful waiting in uncomplicated acute otitis media can be useful but remains underutilized. Read more: pharmacy.uconn.edu/pediatric-id... #PedsIDsky #PedsRxsky

🧬 COVID-19 vaccine strain update for pharmacists: FDA has recommended th 2026-2027 COVID-19 vaccines for fall 2026 should be monovalent vaccines targeting the JN.1-lineage XFG variant. www.fda.gov/vaccines-blo... #PedsIDsky #PedsRxsky

COVID-19 Vaccines (2026-2027 Formula) for Use in the United States Beg

COVID-19 Vaccines (2026-2027 Formula) for Use in the United States Beginning in Fall 2026

fda.gov

Nirsevimab may protect babies from severe RSV better than maternal vaccination. But timing matters: When administered at least 8 weeks before delivery, maternal vaccination appears equally effective. Read more: ow.ly/weWR50YYsGE

Great presentation by Jordan at #PediatRxCon35

🔁1/10 🧵 Pharmacy Update | 💬 ⚕️ By UConn P4 Nicole P 🚨 FDA Update (Dec 2025)🚨 Two new ORAL antibiotics, Nuzolvence (zoliflodacin) & Blujepa (gepotidacin), are now approved for uncomplicated urogenital gonorrhea in patients ≥12 years old FDA News Release: shorturl.at/E0CpI

FDA Approves Two Oral Therapies to Treat Gonorrhea

The U.S. Food and Drug Administration recently approved two new oral medicines to treat a common sexually transmitted infection called gonorrhea.

shorturl.at

PIDS applauds today’s momentous federal court finding that the dismissal and reconstitution of the ACIP and anomalous changes made by the Secretary of Health and Human Services to the childhood immunization schedule were likely unlawful. Statement: pids.org/2026/03/16/p...

Pediatric CAP Duration Update | UConn P4 💬 ⚕️🏥 By Nicole P "How Long Should We Treat Pediatric Outpatient CAP? Rethinking Antibiotic Duration" Posted March 6, 2026 pharmacy.uconn.edu/pediatric-id...

Note these components are all different than what was included in the 2025-2026 flu vaccines.

Peds ID PharmD@pedsidpharmd.bsky.social · 5mo ago

🧵FDA advisory committee has voted to recommend the following components for the 2026-2027 influenza vaccines

🧵FDA advisory committee has voted to recommend the following components for the 2026-2027 influenza vaccines

FDA having their influenza vaccine advisory committee meeting today to vote on products for the 2026-2027 season. This will also include information on current vaccine effectiveness and likely circulating strains. Meeting live at www.youtube.com/live/WKw0WEi...

Vaccines and Related Biological Products Advisory Committee Meeting

YouTube video by U.S. Food and Drug Administration

youtube.com

🔁 🧵 Pharmacy Update | UConn P4 HPV Immunization Review 💬 ⚕️💉 By Megan.

Another recent publication w/the PPA Immunization Committee, we highlight the importance of the hepatitis B vaccine at birth. 👶💉 🔗 jppt.kglmeridian.com/view/journal... #PedsIDsky #Rxsky

Here is is our PPA Immunization Committee publication to support pharmacists in immunization practice. 💉📚 This article provides evidence-informed strategies and practical resources to strengthen vaccine conversations with families. 🔗 jppt.kglmeridian.com/view/journal... #PedsIDsky #Rxsky

Bacterial arthritis in pediatrics, key takeaways for pharmacy practice by Kenna Riley. www.instagram.com/p/DTvxxhOiUq... Full article available pharmacy.uconn.edu/pediatric-id... #Rxsky

Peds ID and Immunization on Instagram: "Pediatric Bacterial Arthritis Takeaways for Pharmacy Practice by Kenna Riley available at: https://pharmacy.uconn.edu/pediatric-id-and-immunization-updates/"

0 likes, 0 comments - pedsidandimmunization on January 20, 2026: "Pediatric Bacterial Arthritis Takeaways for Pharmacy Practice by Kenna Riley available at: https://pharmacy.uconn.edu/pediatric-id-and...

instagram.com

💬 Perspective: The rise of H3N2 subclade K may increase severe #influenza outcomes this season; available vaccines and antivirals remain important tools for prevention and treatment. ja.ma/3MVJMt1

🧵 CDC FluView Update (12/19) 📈 Flu activity is rising: 2nd week above baseline 🤒 ILI ~4% nationwide 🧪 Flu test positivity ↑ ~15% this week 🔗 CDC FluView Week 50: www.cdc.gov/fluview/surv... #PedsIDsky #RXsky

Weekly US Influenza Surveillance Report: Key Updates for Week 50, ending December 13, 2025

Seasonal influenza activity is low.

cdc.gov

📢 In a time where vaccine hesitancy is rising, the Pediatric Pharmacy Association’s Immunization Committee has published guidance on how to build immunization confidence through communication, education, and trusted resources. Read more here: jppt.kglmeridian.com/view/journal... #Rxsky

Grateful for the clear messages coming from @ameracadpeds.bsky.social @idsainfo.bsky.social @apha.org

The decision by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention to downgrade its recommendations to protect infants from hepatitis B is a dangerous move that will harm children. Click here to read AAP's full statement: bit.ly/3Y9ZQJT

#ACIP votes to change the #hepatitisB #vaccine birth dose recommendation, ending the universal birth dose policies that have almost eliminated neonatal hepatitis B infection, cut pediatric infections by more than 95%, and prevented more than 6 million infections / a million hospitalizations.

New review finds no evidence to support delaying universal hepatitis B birth-dose vaccination

cidrap.umn.edu

It's hard to predict what the new #ACIP will do, but it looks like it will recommend that the universal birth dose for #hepatitisB be jettisoned. Experts warn even a delay of 2 months before the first dose will lead to chronically infected kids & deaths. www.statnews.com/2025/12/04/c...

CDC vaccine advisers appear likely to recommend delaying hepatitis B vaccine birth dose

A panel that issues advice on U.S. vaccine policy appears prepared to vote Thursday to recommend a delay in when most babies begin to be vaccinated against hepatitis B.

statnews.com

ACIP meeting is about to start. The updated proposed HepB vote language has been posted. www.cdc.gov/acip/meeting... This language is confusing and if passed will result in more infants exposed.

The vote was slightly different than what was published and was delayed until tomorrow so members were able to fully review the updated options and language before voting.

Peds ID PharmD@pedsidpharmd.bsky.social · 9mo ago

🚨 ACIP is proposing new HepB birth-dose language today. 👉 www.cdc.gov/acip/meeting... Concerns: • Birth dose prevents lifelong HepB, liver cancer & liver disease • It remains a key public-health tool • Why the U.S. adopted this strategy 👉 pharmacy.uconn.edu/2025/10/06/h... #PedsIDsky #Rxsky

A study cited in today's ACIP meeting about Hep B and SIDS was misrepresented. The study's authors themselves have refuted an association.

If anyone is looking for a bit more in depth info on the HBV vaccine, you may find this helpful www.cidrap.umn.edu/vaccine-inte...

Edward Nirenberg@enirenberg.bsky.social · 9mo ago

As a reminder, today's meeting is all about hepatitis B (HBV) vaccination, specifically the dose of vaccine given within 24 hours of birth universally. This is a critically important policy intervention that enabled us to drastically reduce the incidence of hepatitis B: www.cdc.gov/mmwr/volumes...

💬Viewpoint: Eliminating universal hepatitis B birth dose vaccination risks an estimated 8% increase in annual perinatal #HepatitisB infections in the US, increasing preventable chronic disease burden. ja.ma/3Me0zHh

Today, ACIP is poised to vote on delaying the hepatitis B vaccine birth dose, a move that could put millions of kids at risk of lifelong disease. Read more about the implications of today’s vote in AAP News: bit.ly/4rBt1TF

The hepatitis B birth dose is an evidence-based measure to prevent cancer. Here’s why it’s so important. www.globalhep.org/news-blogs/a...

Answering Key Questions on Hepatitis B Birth Dose at a Critical Time | CGHE

globalhep.org

Hepatitis B vaccines are safe, and a successful public health measure we've used for decades. www.voicesforvaccines.org/jtf_topics/d...

Do studies show that vaccines are safe?

Explore the truth behind vaccine safety as we debunk claims that Hepatitis B clinical trials lacked thorough monitoring, emphasizing vaccines’ proven benefits.

voicesforvaccines.org